Verantos

United States
New Lisbon, Wisconsin, United States

Company profile

Verantos company profile

Verantos is the market leader in high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, artificial intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Grant / $1.2M / 2020-12-20
Investors
1
Lead investors
1
Founders
1
Articles
29

Founders and investors

Founders

Dan Riskin

Lead investors

National Science Foundation

Investors

National Science Foundation